Maxinsheng announced that in the first half of 2026, it achieved operating income of 278 million yuan, an increase of 4.85% over the previous year; net loss attributable to shareholders of listed companies was 5.134,300 yuan, which changed from profit to loss over the previous year; net loss after deducting non-recurring profit and loss was 11.898 million yuan, an increase in year-on-year losses. R&D investment was 84.4486 million yuan, and R&D investment accounted for 30.38% of revenue, an increase of 2.53 percentage points over the previous year. The change in performance was mainly due to a 2.32 percentage point year-on-year decrease in gross margin due to continued price increases for upstream wafers and packaging, compounded by an increase in R&D investment. As of June 30, 2026, a total of 1,122 million yuan of capital raised has been invested and used in compliance; shares held by controlling shareholders, actual controllers, directors and supervisors have not been pledged, frozen, or reduced.

Maxinsheng announced that in the first half of 2026, it achieved operating income of 278 million yuan, an increase of 4.85% over the previous year; net loss attributable to shareholders of listed companies was 5.134,300 yuan, which changed from profit to loss over the previous year; net loss after deducting non-recurring profit and loss was 11.898 million yuan, an increase in year-on-year losses. R&D investment was 84.4486 million yuan, and R&D investment accounted for 30.38% of revenue, an increase of 2.53 percentage points over the previous year. The change in performance was mainly due to a 2.32 percentage point year-on-year decrease in gross margin due to continued price increases for upstream wafers and packaging, compounded by an increase in R&D investment. As of June 30, 2026, a total of 1,122 million yuan of capital raised has been invested and used in compliance; shares held by controlling shareholders, actual controllers, directors and supervisors have not been pledged, frozen, or reduced.